First introductory press conference about the CTC method and blood biopsy

Can we say that humanity is one step ahead of cancer, having the ability to diagnose a malignant process with high accuracy at the earliest stage, without the presence of symptoms? During the press conference held on March 9, 2023 in Sofia, Hill Clinic announced its new partnership with Datar Cancer Genetics and Diagnostika, Spain. We announced the launch of blood tests for early cancer diagnosis.

Leading developer Datar Cancer Genetics introduces CTC tests, which are considered to be an absolute revolution in cancer diagnostics. Unlike the traditional tissue biopsy, the blood biopsy is non-invasive and gentle, only requires a simple blood sample from the vein. Bulgaria is among the first ten countries in Europe where it will be avaliable along with Great Britain, Germany, Spain, and Poland. 

"We can diagnose cells or groups of cells that are found in the blood. Cancer is diagnosed at various stages, including early stages, when there are no symptoms yet. Trucheck uses a single venous blood sample. Prof. Benchev explained during his speech. "Recommended for asymptomatic individuals who have a family history of cancer and those looking for a reliable screening method. The advantage of this new method is that it is universal for over 70 types of cancer.”

"The method has been verified with thousands of patients - with and without symptoms, and the results have been published in clinical studies. The test looks for cells that have a different apoptotic mechanism. Solid tumors secrete circulating tumor cells in more than 90% of patients. This method is applicable to different degrees of the disease. It can be used for screening or for symptomatic patients to test for organ-specific cells. We offer three very common types of cancer – prostate cancer, breast cancer and gliomas in the brain, we have FDA approval for a breakthrough in medicine.” Dr. Schuster said.

"It's been a longtime dream for us to have a single test that can tell if a patient has any type of cancer. Thanks to the scientific achievements of Datar Cancer Genetics, we now have a test that diagnoses 70 types of cancer with high reliability," noted Dr. Fernando Sancha.

Participants in the press conference were:

Prof. Dr. Rumen Benchev, specialist in otorhinolaryngology at Hill Clinic;
Dr. Stefan Schuster, Doctor of Medicinal Chemistry, Managing Director of Datar Cancer Genetics Europe GmbH;
Dr. Fernando Sancha, leading urologist and head of the operating team at the Hill Clinic, co-founder and medical director of the Institute of Advanced Urological Surgery (ICUA) in Madrid and a pioneer in the work with Green Laser, Holmium Laser for Vaporization of the Prostate (PVP) and for laser enucleation in Spain;
Dr. Alexander Bocevski, urologist at Hill Clinic;
Dr. Georgi Georgiev, urologist at Hill Clinic;
Santiago Sancha, Director of Diagnostika, Madrid, partners of Hill Clinic - Sofia.